Ponatinib Represses Latent HIV-1 by Inhibiting AKT-mTOR

Ting Huang(Ganzhou People's Hospital), Kai Deng(Capital University)

Antimicrobial Agents and Chemotherapy

May 22, 2023

10.1128/aac.00067-23

Cited by 14

Related Papers

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

|Immunity|2012|707

Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations

|Nature|2015|501

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

|Nature Medicine|2021|367

Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection

|Immunity|2017|184

Supplementation with organic acids showing different effects on growth performance, gut morphology and microbiota of weaned pigs fed with highly or less digestible diets

|Journal of Animal Science|2018|62